NewsRamp is a PR & Newswire Technology platform that enhances press release distribution by adapting content to align with how and where audiences consume information. Recognizing that most internet activity occurs outside of search, NewsRamp improves content discovery by programmatically curating press releases into multiple unique formats—news articles, blog posts, persona-based TLDRs, videos, audio, and Zero-Click content—and distributing this content through a network of news sites, blogs, forums, podcasts, video platforms, newsletters, and social media.
HKSTP Leads Largest Hong Kong Delegation to BIO 2026: Key Highlights and Partnerships
HKSTP led the largest-ever Hong Kong delegation to BIO 2026 in San Diego, featuring 41 local tech firms and university spin-offs. The event showcased Hong Kong's biotech strengths and resulted in strategic partnerships to boost cross-border innovation.
The delegation aimed to forge global partnerships, showcase Hong Kong's life and health technology strengths, and reinforce the city's status as an international healthcare innovation hub.
The 2026 delegation was the largest-ever, doubling the size of the Hong Kong Pavilion to a record 41 organisations, including partner companies, research institutes, and for the first time, spin-offs from five top universities.
The delegation was co-organised by HKSTP and InvestHK, with support from the Hong Kong Trade Development Council (HKTDC) and five local universities: The University of Hong Kong, The Chinese University of Hong Kong, The Hong Kong University of Science and Technology, The Hong Kong Polytechnic University, and City University of Hong Kong.
Two major partnerships were highlighted: an MOU between HKSTP and LabCentral, a global non-profit biotech incubator, to deepen US-Hong Kong ties; and a collaboration between Immuno Cure (developer of HIV vaccine ICVAX) and OPIS, an international CRO, to support overseas clinical trials.
BIO 2026 was held in San Diego, United States, from June 22 to 25, 2026.
Hong Kong is Asia's largest and the world's second largest fundraising hub for the biotechnology sector.
Hong Kong has strong R&D capabilities backed by five QS Top 100 universities, including two with medical schools in the global top 20, highlighting excellence in biotech and medical research.
The delegation showcased innovations across AI-enabled biotech, therapeutics, diagnostics, and pharma, including potential 'First-in-Class' and 'Best-in-Class' assets.